US-listed stock · Healthcare · Pharmaceuticals and vaccines · close 16 Nov 2026
Close
$144.46
Day change
-2.2%
1 month
-1.0%
6 months
+29.7%
1 year
+55.5%
3 years
+41.6%
5 years
+71.8%
From 52-week high
-7.7%
Weinstein stage
Stage 2
Merck closed at $144.46 on 16 Nov 2026. Over the past year it has gained 55.5%, and over five years +72% in all (+11.4% a year). It is 7.7% below its 52-week closing high of $156.45, set on 25 Aug 2026, and 55.6% above its 52-week closing low of $92.86. The price is above its 200-day average of $128.82 - an average that is itself still rising. On Stan Weinstein's stage analysis it is in Stage 2: advancing - above a rising 150-day average. Its deepest fall from a peak in the period shown was 45%.
Price, RSI and MACD
Price · +26.5% over the period
RSI (14) · 46.7
MACD (12, 26, 9) · histogram -0.13
Price · +55.5% over the period
RSI (14) · 46.7
MACD (12, 26, 9) · histogram -0.13
Price · +46.5% over the period
RSI (14) · 46.7
MACD (12, 26, 9) · histogram -0.13
Price · +42.5% over the period
RSI (14) · 46.7
MACD (12, 26, 9) · histogram -0.13
Price · +72.6% over the period
RSI (14) · 46.7
MACD (12, 26, 9) · histogram -0.13
Price: daily close adjusted for stock splits, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.
50-day average $146.02 · 200-day average $128.82 · 52-week closing range $92.86 – $156.45
Daily closes to 16 Nov 2026, adjusted for stock splits (not dividends), from Google Finance and Yahoo Finance. US stock prices in US dollars; index levels in points. Figures may be delayed and are for information only.
For research & education only — not investment advice or a recommendation to buy or sell any security. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by any exchange or index provider. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.